Experienced in Scrofula

Pietro Pirina

Sassari, IT 
Experienced in Scrofula
Sassari, IT 
OverviewLocationsClinical Research

Overview

Pietro Pirina practices in Sassari, Italy. Mr. Pirina is rated as an Experienced expert by MediFind in the treatment of Scrofula. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Bronchitis, Asthma, Lymphofollicular Hyperplasia, and Endoscopy.

His clinical research consists of co-authoring 130 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Scrofula.

Gender
Male

Locations

Sassari, 07100, Italy
Other Locations
Catanzaro, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
Enrollment Status: Completed
Publish Date: October 15, 2025
Intervention Type: Biological, Drug, Device
Study Drugs: Depemokimab, Mepolizumab, Benralizumab
Study Phase: Phase 3

130 Total Publications

NOX-derived ROS generation drives endothelial-to-mesenchymal transition in human pulmonary endothelial cells exposed to sera from patients with idiopathic pulmonary fibrosis.
NOX-derived ROS generation drives endothelial-to-mesenchymal transition in human pulmonary endothelial cells exposed to sera from patients with idiopathic pulmonary fibrosis.
Journal: Journal of cardiovascular pharmacology
Published: October 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Pirina's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 25 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile